NCT01409759

Brief Summary

Objective: to evaluate the perforator based interposition plasty in comparison to the standard technique (full thickness graft) for scar contracture releases. Study design: A randomised controlled multicentre intervention study. Study population: Patients, aged 18 years and older, who require surgery for release of a scar contracture, are eligible for this study. In total 50 patients will be recruited with a follow-up of 3 months post-operatively. Intervention: A release of the contracture will be performed in combination with òr the standard technique (full thickness graft) òr the perforator based interposition plasty. Main study parameters/endpoints: the main study parameter is the amount of contraction of the flap/graft after three months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 3, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 4, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

June 26, 2015

Status Verified

June 1, 2015

Enrollment Period

1.8 years

First QC Date

August 3, 2011

Last Update Submit

June 25, 2015

Conditions

Keywords

PerforatorsInterposition plastyContracture release

Outcome Measures

Primary Outcomes (1)

  • Expansion/contraction of the interpositioned skin after 3 months

    Is interpositioned skin of superior quality, as represented by less contraction with the use of the perforator based interposition flaps, compared to the gold standard (full thickness grafts), after 3 months, as measured by transparent sheet planimetry?

    3 months

Study Arms (2)

Perforator based interposion flap

EXPERIMENTAL

In our concept the flap is designed based on a selected perforator and locally available, preferably normal skin adjacent to the burn scar contracture. The flap consists of skin and underlying subcutaneous tissue. Based on the pre-operative defined perforator, the required length and width and the available preferable normal skin, a design for the perforator flap is made.

Procedure: Perforator based interposition flap

Full thickness graft

OTHER
Procedure: Perforator based interposition flap

Interventions

The flap is designed based on a selected perforator and locally available, preferably normal skin adjacent to the burn scar contracture. The flap consists of skin and underlying subcutaneous tissue. Based on the pre-operative defined perforator, the required length and width and the available preferable normal skin, a design for the perforator flap is made.

Full thickness graftPerforator based interposion flap

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indication for release of burn scar contracture
  • Sufficient tissue for a perforator- based interposition flap (preferably normal skin)
  • Able to give informed consent

You may not qualify if:

  • Age \< 18 years
  • Location: scars on the face and scalp
  • Smoking (however, the patient is eligible if smoking is quit \> 3 weeks before the operation)
  • Psychiatric disorders (if a loss to follow-up is anticipated)
  • Language barrier

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Red Cross Hospital

Beverwijk, North Holland, 1942 LE, Netherlands

Location

Maastad Hospital

Rotterdam, South Holland, 3079 DZ, Netherlands

Location

Martini Hospital, Burns centre

Groningen, 9728 NZ, Netherlands

Location

Study Officials

  • Paul P M Van Zuijlen, Prof

    Red Cross Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 3, 2011

First Posted

August 4, 2011

Study Start

July 1, 2011

Primary Completion

May 1, 2013

Study Completion

November 1, 2013

Last Updated

June 26, 2015

Record last verified: 2015-06

Locations